Mei B, Li J, Wang D, Feng L, Huang J, Zhang G
Mol Cancer Ther. 2024; 24(3):453-463.
PMID: 39676352
PMC: 11876957.
DOI: 10.1158/1535-7163.MCT-24-0140.
Ravindranathan R, Somuncu O, da Costa A, Mukkavalli S, Lamarre B, Nguyen H
Proc Natl Acad Sci U S A. 2024; 121(47):e2413954121.
PMID: 39546575
PMC: 11588084.
DOI: 10.1073/pnas.2413954121.
Al-Rahahleh R, Sobol R
Environ Mol Mutagen. 2024; 65(9):315-337.
PMID: 39221603
PMC: 11604531.
DOI: 10.1002/em.22623.
Kulkarni S, Gajjar K, Madhusudan S
Front Oncol. 2024; 14:1414112.
PMID: 39135999
PMC: 11317305.
DOI: 10.3389/fonc.2024.1414112.
Saville K, Al-Rahahleh R, Siddiqui A, Andrews M, Roos W, Koczor C
DNA Repair (Amst). 2024; 140:103700.
PMID: 38897003
PMC: 11239280.
DOI: 10.1016/j.dnarep.2024.103700.
Poly (ADP-ribose) polymerase 1 promotes HuR/ELAVL1 cytoplasmic localization and inflammatory gene expression by regulating p38 MAPK activity.
Fu X, Zhang J, Sun K, Zhang M, Wang S, Yuan M
Cell Mol Life Sci. 2024; 81(1):253.
PMID: 38852108
PMC: 11335290.
DOI: 10.1007/s00018-024-05292-2.
PARP1 UFMylation ensures the stability of stalled replication forks.
Gong Y, Wang Z, Zong W, Shi R, Sun W, Wang S
Proc Natl Acad Sci U S A. 2024; 121(18):e2322520121.
PMID: 38657044
PMC: 11066985.
DOI: 10.1073/pnas.2322520121.
Mechanism and regulation of secondary immunoglobulin diversification.
Bello A, Hirth G, Voigt S, Tepper S, Jungnickel B
Cell Cycle. 2023; 22(18):2070-2087.
PMID: 37909747
PMC: 10761156.
DOI: 10.1080/15384101.2023.2275397.
Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review).
Belenchon I, Congregado Ruiz C, Saez C, Osman Garcia I, Medina Lopez R
Int J Mol Sci. 2023; 24(16).
PMID: 37629155
PMC: 10455664.
DOI: 10.3390/ijms241612978.
Regulation of Biomolecular Condensates by Poly(ADP-ribose).
Rhine K, Odeh H, Shorter J, Myong S
Chem Rev. 2023; 123(14):9065-9093.
PMID: 37115110
PMC: 10524010.
DOI: 10.1021/acs.chemrev.2c00851.
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer.
Veneziani A, Scott C, Wakefield M, Tinker A, Lheureux S
Ther Adv Med Oncol. 2023; 15:17588359231157644.
PMID: 36872947
PMC: 9983116.
DOI: 10.1177/17588359231157644.
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors.
Golder A, Nelson L, Tighe A, Barnes B, Coulson-Gilmer C, Morgan R
NAR Cancer. 2022; 4(4):zcac036.
PMID: 36381271
PMC: 9653014.
DOI: 10.1093/narcan/zcac036.
Targeting replication stress in cancer therapy.
da Costa A, Chowdhury D, Shapiro G, DAndrea A, Konstantinopoulos P
Nat Rev Drug Discov. 2022; 22(1):38-58.
PMID: 36202931
PMC: 11132912.
DOI: 10.1038/s41573-022-00558-5.
Functional roles of ADP-ribosylation writers, readers and erasers.
Li P, Lei Y, Qi J, Liu W, Yao K
Front Cell Dev Biol. 2022; 10:941356.
PMID: 36035988
PMC: 9404506.
DOI: 10.3389/fcell.2022.941356.
Physiological levels of poly(ADP-ribose) during the cell cycle regulate HeLa cell proliferation.
Yamashita S, Tanaka M, Ida C, Kouyama K, Nakae S, Matsuki T
Exp Cell Res. 2022; 417(1):113163.
PMID: 35447104
PMC: 10009817.
DOI: 10.1016/j.yexcr.2022.113163.
Efficient DNA Repair Mitigates Replication Stress Resulting in Less Immunogenic Cytosolic DNA in Radioresistant Breast Cancer Stem Cells.
Meyer F, Engel A, Krause A, Wagner T, Poole L, Dubrovska A
Front Immunol. 2022; 13:765284.
PMID: 35280989
PMC: 8913591.
DOI: 10.3389/fimmu.2022.765284.
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms.
Huang D, Kraus W
Mol Cell. 2022; 82(12):2315-2334.
PMID: 35271815
PMC: 9232969.
DOI: 10.1016/j.molcel.2022.02.021.
Genomic Instability and Replicative Stress in Multiple Myeloma: The Final Curtain?.
Botrugno O, Tonon G
Cancers (Basel). 2022; 14(1).
PMID: 35008191
PMC: 8750813.
DOI: 10.3390/cancers14010025.
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword.
Csizmar C, Saliba A, Swisher E, Kaufmann S
Cancers (Basel). 2021; 13(24).
PMID: 34945003
PMC: 8699275.
DOI: 10.3390/cancers13246385.
NAD bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells.
Li J, Saville K, Ibrahim M, Zeng X, McClellan S, Angajala A
NAR Cancer. 2021; 3(4):zcab044.
PMID: 34806016
PMC: 8600031.
DOI: 10.1093/narcan/zcab044.